256 related articles for article (PubMed ID: 27716191)
1. Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
Ji X; Fu T; Bu ZD; Zhang J; Wu XJ; Zong XL; Jia ZY; Fan B; Zhang YN; Ji JF
BMC Cancer; 2016 Oct; 16(1):765. PubMed ID: 27716191
[TBL] [Abstract][Full Text] [Related]
2. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
[TBL] [Abstract][Full Text] [Related]
3. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the short- and long-term outcomes of membrane anatomy-guided laparoscopic spleen-preserving circumferential splenic hilar lymph node dissection for treating advanced proximal gastric cancer.
Xu Y; Li Z; Pan G; Wu H; Lin W; Chen J; Li J
World J Surg Oncol; 2019 Apr; 17(1):64. PubMed ID: 30967144
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].
Zhang CH; Wu AW; Li ZY; Zhang LH; Bu ZD; Wu XJ; Zong XL; Li SX; Shan F; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):589-92. PubMed ID: 21866448
[TBL] [Abstract][Full Text] [Related]
6. Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
Ding P; Gao Z; Zheng C; Chen J; Li K; Gao S
BMC Cancer; 2019 Sep; 19(1):905. PubMed ID: 31510966
[TBL] [Abstract][Full Text] [Related]
7. [Surgical selection and metastatic warning of splenic lymph node dissection in advanced gastric cancer radical surgery: a prospective, single-center, randomized controlled trial].
Guo X; Bian SB; Peng Z; Wang N; Wei B; Cui JX; Wang XX; Xie TY; Xi HQ; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):144-151. PubMed ID: 32074794
[No Abstract] [Full Text] [Related]
8. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
[TBL] [Abstract][Full Text] [Related]
9. Ex Situ In Vivo Technique of Spleen-Preserving Splenic Hilar Lymph Node Dissection in Operable Proximal Gastric Adenocarcinoma.
Kalyanasundarabharathi VC; Kolandasamy C; Prabhakaran R; Ambedkar MJC; Balram A; Rajendran S; Lakshmanamoorthy NBO
Indian J Surg Oncol; 2022 Sep; 13(3):481-487. PubMed ID: 36187512
[TBL] [Abstract][Full Text] [Related]
10. Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer.
Yang K; Cho M; Roh CK; Seo WJ; Choi S; Son T; Kim HI; Hyung WJ
Surg Endosc; 2019 Jul; 33(7):2357-2363. PubMed ID: 30945060
[TBL] [Abstract][Full Text] [Related]
11. [Technical points of laparoscopic splenic hilar lymph node dissection--The original intention of CLASS-04 research design].
Huang C; Lin M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):143-147. PubMed ID: 29492911
[TBL] [Abstract][Full Text] [Related]
12. Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma.
Li C; Kim S; Lai JF; Oh SJ; Hyung WJ; Choi WH; Choi SH; Zhu ZG; Noh SH
Eur J Surg Oncol; 2009 Jul; 35(7):709-14. PubMed ID: 18455906
[TBL] [Abstract][Full Text] [Related]
13. The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.
Ji X; Yan Y; Bu ZD; Li ZY; Wu AW; Zhang LH; Wu XJ; Zong XL; Li SX; Shan F; Jia ZY; Ji JF
BMC Cancer; 2017 May; 17(1):345. PubMed ID: 28526077
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of splenectomy on advanced proximal gastric cancer with No. 10 lymph node metastasis.
Huang CM; Wang JB; Lu HS; Zheng CH; Li P; Xie JW; Zhang XF
Chin Med J (Engl); 2009 Nov; 122(22):2757-62. PubMed ID: 19951610
[TBL] [Abstract][Full Text] [Related]
15. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
16. Role of 3DCT in laparoscopic total gastrectomy with spleen-preserving splenic lymph node dissection.
Wang JB; Huang CM; Zheng CH; Li P; Xie JW; Lin JX; Lu J
World J Gastroenterol; 2014 Apr; 20(16):4797-805. PubMed ID: 24782634
[TBL] [Abstract][Full Text] [Related]
17. The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study.
Huang CM; Chen T; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
Surg Endosc; 2017 Mar; 31(3):1383-1392. PubMed ID: 27450211
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of combined splenectomy in proximal gastric cancer with No.10 lymph node metastasis].
Wang JB; Huang CM; Lu HS; Zheng CH; Li P; Xie JW; Zhang XF
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):121-5. PubMed ID: 19296243
[TBL] [Abstract][Full Text] [Related]
19. [Current status and research progress of lymph node dissection in advanced upper gastric cancer].
Zhang J; Wang J; Hu W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):236-240. PubMed ID: 29492924
[TBL] [Abstract][Full Text] [Related]
20. Spleen-preserving lymphadenectomy versus splenectomy in laparoscopic total gastrectomy for advanced gastric cancer.
Son SY; Shin DJ; Park YS; Oo AM; Jung DH; Lee CM; Ahn SH; Park DJ; Kim HH
Surg Oncol; 2017 Jun; 26(2):207-211. PubMed ID: 28577727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
